BioSapien Secures Manufacturing Partners for MediChip Trials
BioSapien has finalized manufacturing partnerships with Roswell Park Comprehensive Cancer Center and BA Sciences ahead of imminent Phase I clinical trials for its MediChip platform. The company has already successfully produced its first GMP-grade clinical batch, which has been transported to the UAE for upcoming patient studies.




